113 Results

People

  1. Shah
    Shah
  2. Giralt
    Giralt
  3. Scordo
    Scordo
  4. Landau
    Landau
  5. Lesokhin
    Lesokhin
  6. Maclachlan
    Maclachlan
  7. Shah
    Shah
  8. Chung
    Chung
  9. Mailankody
    Mailankody
  10. Hassoun
    Hassoun

Groups

  1. Bone Marrow Transplant (113)
  2. Center for Hematologic Malignancies (113)
  3. Department of Medicine (113)
  4. GME, Medicine (113)
  5. Graduate Medical Education (113)
  6. Hematologic Malignancies, Division of (113)
  7. Survivorship Research (113)
  8. CTCR Scholars (97)
  9. Epidemiology and Biostatistics (75)
  10. Sloan Kettering Institute Postdocs (72)
  1. "Hematologic Malignancies, Division of"
  2. "Bone Marrow Transplant"
  3. "Survivorship Research"
  4. "Department of Medicine"
  5. "GME, Medicine"
Formats
  1. Meeting Abstract (81)
  2. Journal Article (26)
  3. Research Letter (4)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Bone Marrow Transplant (113)
  2. Center for Hematologic Malignancies (113)
  3. Department of Medicine (113)
  4. GME, Medicine (113)
  5. Graduate Medical Education (113)
  6. Hematologic Malignancies, Division of (113)

More Groups

People
  1. Gunjan Shah (82)
  2. Sergio Giralt (78)
  3. Michael Scordo (73)
  4. Heather Landau (59)
  5. Alexander Lesokhin (58)
  6. Kylee Maclachlan (57)

More People

Years
  1. 2024 (2)
  2. 2023 (51)
  3. 2022 (42)
  4. 2021 (12)
  5. 2020 (2)
  6. 2018 (2)

More Years

Publications
  1. Blood (51)
  2. Clinical Lymphoma, Myeloma and Leukemia (18)
  3. Journal of Clinical Oncology (9)
  4. Transplantation and Cellular Therapy (8)
  5. American Journal of Hematology (3)
  6. Blood Advances (3)

More Publications

Publishers
  1. American Society of Hematology (54)
  2. Elsevier Inc. (26)
  3. American Society of Clinical Oncology (9)
  4. Nature Publishing Group (7)
  5. American Association for Cancer Research (4)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (113)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune-related colitis is associated with fecal microbial dysbiosis and can be mitigated by fecal microbiota transplantation
    Journal Article

    Elkrief, A.; Waters, N. R.; Smith, N.; Dai, A.; Slingerland, J.; Aleynick, N.; Febles, B.; Gogia, P.; Socci, N. D.; Lumish, M.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Efficacy of brentuximab vedotin maintenance therapy following autologous stem cell transplantation in patients with relapsed/refractory classical Hodgkin lymphoma with and without pre-transplant exposure to novel agents
    Meeting Abstract

    Falade, A. S.; Redd, R. A.; Shah, H.; Baron, K.; Iyengar, S.; Desai, S. H.; Ansell, S. M.; Micallef, I.; Nedved, A.; Ganesan, N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Analysis of 3,843 unrelated donors (URD) for 455 allograft candidates reveals low URD availability with marked racial/ ethnic disparities: Major implications for transplant center & registry operations
    Meeting Abstract

    Fingrut, W. B.; Davis, E.; Archer, A.; Brown, S.; Devlin, S. M.; Nhaissi, M.; Rapoport, C.; Chinapen, S.; Kelly, A.; Wells, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Impact of response to systemic bridging therapy on clinical outcomes and cytokine profiles in patients receiving CD19-CAR T-cell therapy for B-cell lymphoma
    Meeting Abstract

    Wills, B.; Shouval, R.; Flynn, J. R.; Devlin, S. M.; Parascondola, A.; Saldia, A.; Imber, B. S.; Tomas, A. A.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • T-cell exhaustion signature predicts early relapse after autologous stem cell transplant for multiple myeloma: BMT CTN 0702 secondary immune analysis
    Meeting Abstract

    Mehanna, N.; Derkach, A.; Gasmi, B.; Anagnostou, T.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save